Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Cancer Res. 2019 Nov 12;80(2):347–353. doi: 10.1158/0008-5472.CAN-19-0725

Figure 3:

Figure 3:

Comparison of validation performance between our multiple primary cancer-specific penetrance and those estimated from Kaplan-Meier (KM) method in predicting the first or the second primary cancer occurrence using the MDACC prospective data. Sample size: n(Affected)=160, n(Unaffected)=320, n(MPC)=58, n(SPC)=102.